
Professor Chris Pemberton
University of Otago Christchurch, Christchurch (New Zealand)
Membership:
ESC Professional Member
Biography
Research Professor at Christchurch Heart Institute, University of Otago, Christchurch, New Zealand. Director of Translational Biodiscovery Laboratory, with interests in novel biomarker discovery, assay technologies and bioactivity of new vasoactive agents.
Also, VP Discovery @ Upstream Medical Technologies, a cardiovascular biomarker company based in New Zealand.
http://www.upstreamdx.com/
Contributor content
Presentation
Assay of macrotroponin I not complexed with troponin T: effect on the performance of troponin T to predict myocardial infarction
Presentation
The signal peptide of CNP is a novel predictor of MI, MACE and bleeding risk in chest pain patients
Presentation
The protein APRIL predicts adverse outcomes in DAPT patients better than NT-proBNP and troponin
Presentation
BNP signal peptide protects the heart from ischemia-reperfusion injury
Presentation
The TNF receptor TACI is a novel inflammatory predictor of heart failure
Presentation

